Literature DB >> 19226231

Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database.

Preeyaporn Srasuebkul1, Poh Lian Lim, Man Po Lee, Nagalingeswaran Kumarasamy, Jialun Zhou, Thira Sirisanthana, Patrick C K Li, Adeeba Kamarulzaman, Shinichi Oka, Praphan Phanuphak, Saphonn Vonthanak, Tuti P Merati, Yi-Ming A Chen, Somnuek Sungkanuparph, Goa Tau, Fujie Zhang, Christopher K C Lee, Rossana Ditangco, Sanjay Pujari, Jun Y Choi, Jeffery Smith, Matthew G Law.   

Abstract

OBJECTIVE: The aim of our study was to develop, on the basis of simple clinical data, predictive short-term risk equations for AIDS or death in Asian patients infected with human immunodeficiency virus (HIV) who were included in the TREAT Asia HIV Observational Database.
METHODS: Inclusion criteria were highly active antiretroviral therapy initiation and completion of required laboratory tests. Predictors of short-term AIDS or death were assessed using Poisson regression. Three different models were developed: a clinical model, a CD4 cell count model, and a CD4 cell count and HIV RNA level model. We separated patients into low-risk, high-risk, and very high-risk groups according to the key risk factors identified.
RESULTS: In the clinical model, patients with severe anemia or a body mass index (BMI; calculated as the weight in kilograms divided by the square of the height in meters) <or= 18 were at very high risk, and patients who were aged <40 years or were male and had mild anemia were at high risk. In the CD4 cell count model, patients with a CD4 cell count <50 cells/microL, severe anemia, or a BMI <or=18 were at very high risk, and patients who had a CD4 cell count of 51-200 cells/microL, were aged <40 years, or were male and had mild anemia were at high risk. In the CD4 cell count and HIV RNA level model, patients with a CD4 cell count <50 cells/microL, a detectable viral load, severe anemia, or a BMI <or=18 were at very high risk, and patients with a CD4 cell count of 51-200 cells/microL and mild anemia were at high risk. The incidence of new AIDS or death in the clinical model was 1.3, 4.9, and 15.6 events per 100 person-years in the low-risk, high-risk, and very high-risk groups, respectively. In the CD4 cell count model the respective incidences were 0.9, 2.7, and 16.02 events per 100 person-years; in the CD4 cell count and HIV RNA level model, the respective incidences were 0.8, 1.8, and 6.2 events per 100 person-years.
CONCLUSIONS: These models are simple enough for widespread use in busy clinics and should allow clinicians to identify patients who are at high risk of AIDS or death in Asia and the Pacific region and in resource-poor settings.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19226231      PMCID: PMC2758295          DOI: 10.1086/597354

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  33 in total

1.  A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA study.

Authors:  Jens D Lundgren; Amanda Mocroft; Jose M Gatell; Bruno Ledergerber; Antonella D'Arminio Monforte; Philippe Hermans; Frank-Detlef Goebel; Anders Blaxhult; Ole Kirk; Andrew N Phillips
Journal:  J Infect Dis       Date:  2002-01-03       Impact factor: 5.226

Review 2.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

3.  More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell counts.

Authors:  A N Phillips; C A Lee; J Elford; A Webster; G Janossy; A Timms; M Bofill; P B Kernoff
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

4.  Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women.

Authors:  Judith A Cook; Jane K Burke-Miller; Mardge H Cohen; Robert L Cook; David Vlahov; Tracey E Wilson; Elizabeth T Golub; Rebecca M Schwartz; Andrea A Howard; Claudia Ponath; Michael W Plankey; Alexandra M Levine; Andrea Levine; Dennis D Grey
Journal:  AIDS       Date:  2008-07-11       Impact factor: 4.177

5.  Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.

Authors:  Raoul Moh; Christine Danel; Eugène Messou; Timothée Ouassa; Delphine Gabillard; Amani Anzian; Yao Abo; Roger Salamon; Emmanuel Bissagnene; Catherine Seyler; Serge Eholié; Xavier Anglaret
Journal:  AIDS       Date:  2007-11-30       Impact factor: 4.177

6.  Anemia and survival in human immunodeficiency virus.

Authors:  Jens D Lundgren; Amanda Mocroft
Journal:  Clin Infect Dis       Date:  2003       Impact factor: 9.079

Review 7.  Natural history of human immunodeficiency virus infection and key predictors of HIV disease progression.

Authors:  N A Hessol; A R Lifson; G W Rutherford
Journal:  AIDS Clin Rev       Date:  1989

8.  Compliance with public sector HIV medical care.

Authors:  P Kissinger; D Cohen; W Brandon; J Rice; A Morse; R Clark
Journal:  J Natl Med Assoc       Date:  1995-01       Impact factor: 1.798

9.  Predictors of disease progression in HIV infection: a review.

Authors:  Simone E Langford; Jintanat Ananworanich; David A Cooper
Journal:  AIDS Res Ther       Date:  2007-05-14       Impact factor: 2.250

10.  Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD).

Authors:  Preeyaporn Srasuebkul; Alexandra Calmy; Jialun Zhou; Nagalingeswaran Kumarasamy; Matthew Law; Poh Lian Lim
Journal:  AIDS Res Ther       Date:  2007-09-17       Impact factor: 2.250

View more
  12 in total

1.  Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program.

Authors:  Victoria Johnston; Katherine L Fielding; Salome Charalambous; Gavin Churchyard; Andrew Phillips; Alison D Grant
Journal:  J Acquir Immune Defic Syndr       Date:  2012-11-01       Impact factor: 3.731

2.  Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa.

Authors:  Didier K Ekouevi; Eric Balestre; Franck-Olivier Ba-Gomis; Serge Paul Eholie; Moussa Maiga; Clarisse Amani-Bosse; Albert Minga; Eugène Messou; Papa Salif Sow; Charlotte Lewden; Hamar Allassane Traoré; Emmanuel Bissagnene; François Dabis
Journal:  Trop Med Int Health       Date:  2010-06       Impact factor: 2.622

Review 3.  Nutrition assessment, counseling, and support interventions to improve health-related outcomes in people living with HIV/AIDS: a systematic review of the literature.

Authors:  Alice M Tang; Timothy Quick; Mei Chung; Christine A Wanke
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-15       Impact factor: 3.731

4.  Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region: results from the TREAT Asia HIV observational database.

Authors:  H Byakwaga; K Petoumenos; J Ananworanich; F Zhang; M A Boyd; T Sirisanthana; P C K Li; C Lee; C V Mean; V Saphonn; S F S Omar; S Pujari; P Phanuphak; P L Lim; N Kumarasamy; Y M A Chen; T P Merati; S Sungkanuparph; R Ditangco; S Oka; G Tau; J Zhou; M G Law; S Emery
Journal:  J Int Assoc Provid AIDS Care       Date:  2013-02-19

Review 5.  Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings.

Authors:  Stephen D Lawn; Anthony D Harries; Robin Wood
Journal:  Curr Opin HIV AIDS       Date:  2010-01       Impact factor: 4.283

6.  Anemia and iron homeostasis in a cohort of HIV-infected patients in Indonesia.

Authors:  Rudi Wisaksana; Rachmat Sumantri; Agnes R Indrati; Aleta Zwitser; Hadi Jusuf; Quirijn de Mast; Reinout van Crevel; Andre van der Ven
Journal:  BMC Infect Dis       Date:  2011-08-09       Impact factor: 3.090

7.  An internationally generalizable risk index for mortality after one year of antiretroviral therapy.

Authors:  Janet P Tate; Amy C Justice; Michael D Hughes; Fabrice Bonnet; Peter Reiss; Amanda Mocroft; Jacob Nattermann; Fiona C Lampe; Heiner C Bucher; Timothy R Sterling; Heidi M Crane; Mari M Kitahata; Margaret May; Jonathan A C Sterne
Journal:  AIDS       Date:  2013-02-20       Impact factor: 4.177

8.  Women experience a better long-term immune recovery and a better survival on HAART in Lao People's Democratic Republic.

Authors:  Mathieu Bastard; Khamphang Soulinphumy; Prasith Phimmasone; Ahmed Hassani Saadani; Laura Ciaffi; Arlette Communier; Chansy Phimphachanh; René Ecochard; Jean-François Etard
Journal:  BMC Infect Dis       Date:  2013-01-22       Impact factor: 3.090

9.  Anaemia in pregnancy is associated with advanced HIV disease.

Authors:  Vikesh Nandlal; Dhayendre Moodley; Anneke Grobler; Jayanthilall Bagratee; Niren R Maharaj; Paul Richardson
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

10.  Advanced HIV Disease at Enrolment in HIV Care: Trends and Associated Factors over a Ten Year Period in Cambodia.

Authors:  Reaksmey Pe; Bopha Chim; Sopheak Thai; Lutgarde Lynen; Johan van Griensven
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.